One thing that was new for me (Not sure if others knew already) was this lil statement.
"We are excited to be collaborating with Sanofi’s Consumer Health team to design and build a smartphone application that would allow consumers to self-assess their respiratory symptoms, and most importantly, provide next steps. This is a challenging task but with the combined strengths of the teams involved we are already making significant progress."
I was always under the impression the app was only for clinics to use. This now branches it to home use which is what I was always hoping for and makes in my opinion the best use case for this tech - Self diagnosis to trigger a visit to the doc.
RAP Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
